RXRX (STOCKS)
Recursion Pharmaceuticals, Inc. Class A Common Stock
$3.300000
+0.010000 (+0.30%)
Prev close: $3.290000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Najat Khan
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,833.68M
- Employees
- 800
- P/E (TTM)
- -3.19
- P/B (TTM)
- 1.92
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $54.86M |
| Benefits Costs and Expenses | $578.32M |
| Cost Of Revenue | $52.94M |
| Costs And Expenses | $598.86M |
| Gross Profit | $1.91M |
| Nonoperating Income/Loss | $20.54M |
| Operating Expenses | $545.92M |
| Research and Development | $394.51M |
| Other Operating Expenses | $151.41M |
| Operating Income/Loss | -$544.01M |
| Income/Loss From Continuing Operations After Tax | -$518.88M |
| Income/Loss From Continuing Operations Before Tax | -$523.47M |
| Income Tax Expense/Benefit | -$4.58M |
| Income Tax Expense/Benefit, Deferred | -$5.19M |
| Net Income/Loss | -$518.88M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$518.88M |
| Net Income/Loss Available To Common Stockholders, Basic | -$518.88M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.00 |
| Diluted Earnings Per Share | -$1.00 |
| Basic Average Shares | 1,533,555,571 |
| Diluted Average Shares | 1,533,555,571 |
| Assets | $1.21B |
| Current Assets | $603.46M |
| Prepaid Expenses | $8.68M |
| Other Current Assets | $594.78M |
| Noncurrent Assets | $609.21M |
| Fixed Assets | $89.62M |
| Intangible Assets | $282.89M |
| Other Non-current Assets | $236.70M |
| Liabilities | $297.67M |
| Current Liabilities | $119.89M |
| Accounts Payable | $12.67M |
| Wages | $17.96M |
| Other Current Liabilities | $89.25M |
| Noncurrent Liabilities | $177.78M |
| Equity | $915.00M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $915.00M |
| Liabilities And Equity | $1.21B |
| Net Cash Flow From Operating Activities | -$350.48M |
| Net Cash Flow From Operating Activities, Continuing | -$350.48M |
| Net Cash Flow From Investing Activities | -$6.09M |
| Net Cash Flow From Investing Activities, Continuing | -$6.09M |
| Net Cash Flow From Financing Activities | $378.61M |
| Net Cash Flow From Financing Activities, Continuing | $378.61M |
| Exchange Gains/Losses | $937.00K |
| Net Cash Flow | $22.98M |
| Net Cash Flow, Continuing | $22.04M |
| Comprehensive Income/Loss | -$534.51M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$534.51M |
| Other Comprehensive Income/Loss | -$534.51M |
| Other Comprehensive Income/Loss Attributable To Parent | -$15.63M |